The Role of APOE-ɛ4 and Beta Amyloid in the Differential Rate of Recovery from ECT: a Review

Overview

Journal Transl Psychiatry

Specialties Psychiatry
Public Health

Date 2015 Apr 1

PMID 25826114

Citations 3

Authors

T A Sutton

H R Sohrabi

S R Rainey-Smith

S M Bird

M Weinborn

R N Martins

Affiliations

Soon will be listed here.

Abstract

Individual biological differences may contribute to the variability of outcomes, including cognitive effects, observed following electroconvulsive treatment (ECT). A narrative review of the research literature on carriage of the apolipoprotein E ɛ4 allele (APOE-ɛ4) and the protein biomarker beta amyloid (Aβ) with ECT cognitive outcome was undertaken. ECT induces repeated brain seizures and there is debate as to whether this causes brain injury and long-term cognitive disruption. The majority of ECT is administered to the elderly (over age 65 years) with drug-resistant depression. Depression in the elderly may be a symptom of the prodromal stage of Alzheimer's disease (AD). Carriage of the APOE-ɛ4 allele and raised cerebral Aβ are consistently implicated in AD, but inconsistently implicated in brain injury (and related syndromes) recovery rates. A paucity of brain-related recovery, genetic and biomarker research in ECT responses in the elderly was found: three studies have examined the effect of APOE-ɛ4 allele carriage on cognition in the depressed elderly receiving ECT, and two have examined Aβ changes after ECT, with contradictory findings. Cognitive changes in all studies of ECT effects were measured by a variety of psychological tests, making comparisons of such changes between studies problematic. Further, psychological test data-validity measures were not routinely administered, counter to current testing recommendations. The methodological issues of the currently available literature as well as the need for well-designed, hypothesis driven, longitudinal studies are discussed.

Citing Articles

Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.

Morozova A, Zorkina Y, Abramova O, Pavlova O, Pavlov K, Soloveva K Int J Mol Sci. 2022; 23(3).

PMID: 35163141 PMC: 8835608. DOI: 10.3390/ijms23031217.

Brain Stimulation in Alzheimer's Disease.

Chang C, Lane H, Lin C Front Psychiatry. 2018; 9:201.

PMID: 29910746 PMC: 5992378. DOI: 10.3389/fpsyt.2018.00201.

Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.

Xu Z, Yang S, Zhao S, Zheng C, Li H, Zhang Y EBioMedicine. 2016; 5:105-13.

PMID: 27077117 PMC: 4816853. DOI: 10.1016/j.ebiom.2016.02.014.

References

Huuhka M, Anttila S, Leinonen E, Huuhka K, Rontu R, Mattila K . The apolipoprotein E polymorphism is not associated with response to electroconvulsive therapy in major depressive disorder. J ECT. 2005; 21(1):7-11. DOI: 10.1097/01.yct.0000153210.25362.ea. View

Verwijk E, Comijs H, Kok R, Spaans H, Stek M, Scherder E . Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: a review. J Affect Disord. 2012; 140(3):233-43. DOI: 10.1016/j.jad.2012.02.024. View

Loo C, Katalinic N, Martin D, Schweitzer I . A review of ultrabrief pulse width electroconvulsive therapy. Ther Adv Chronic Dis. 2012; 3(2):69-85. PMC: 3513900. DOI: 10.1177/2040622311432493. View

Edwards E, Spira A, Barnes D, Yaffe K . Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia. Int J Geriatr Psychiatry. 2009; 24(7):716-22. PMC: 2735341. DOI: 10.1002/gps.2187. View

Rothman S, Olney J . Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol. 1986; 19(2):105-11. DOI: 10.1002/ana.410190202. View

Bousman C, Katalinic N, Martin D, Smith D, Ingram A, Dowling N . Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy. J ECT. 2014; 31(2):129-35. DOI: 10.1097/YCT.0000000000000170. View

Strittmatter W, Saunders A, Schmechel D, Pericak-Vance M, Enghild J, Salvesen G . Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993; 90(5):1977-81. PMC: 46003. DOI: 10.1073/pnas.90.5.1977. View

Bonilha L, Elm J, Edwards J, Morgan P, Hicks C, Lozar C . How common is brain atrophy in patients with medial temporal lobe epilepsy?. Epilepsia. 2010; 51(9):1774-9. DOI: 10.1111/j.1528-1167.2010.02576.x. View

Palmio J, Huuhka M, Laine S, Huhtala H, Peltola J, Leinonen E . Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein. Psychiatry Res. 2010; 177(1-2):97-100. DOI: 10.1016/j.psychres.2009.01.027. View

10.

Sienaert P, Vansteelandt K, Demyttenaere K, Peuskens J . Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects. J Affect Disord. 2009; 122(1-2):60-7. DOI: 10.1016/j.jad.2009.06.011. View

11.

MacQueen G, Parkin C, Marriott M, Begin H, Hasey G . The long-term impact of treatment with electroconvulsive therapy on discrete memory systems in patients with bipolar disorder. J Psychiatry Neurosci. 2007; 32(4):241-9. PMC: 1911194. View

12.

Sackeim H, Prudic J, Fuller R, Keilp J, Lavori P, Olfson M . The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2006; 32(1):244-54. DOI: 10.1038/sj.npp.1301180. View

13.

Van Paesschen W, Revesz T, Duncan J, King M, Connelly A . Quantitative neuropathology and quantitative magnetic resonance imaging of the hippocampus in temporal lobe epilepsy. Ann Neurol. 1997; 42(5):756-66. DOI: 10.1002/ana.410420512. View

14.

van der Wurff F, Stek M, Hoogendijk W, Beekman A . The efficacy and safety of ECT in depressed older adults: a literature review. Int J Geriatr Psychiatry. 2003; 18(10):894-904. DOI: 10.1002/gps.944. View

15.

Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U, Wolgast M . Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res. 2003; 122(3):185-92. DOI: 10.1016/s0925-4927(03)00003-9. View

16.

Glenner G, Wong C . Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984; 120(3):885-90. DOI: 10.1016/s0006-291x(84)80190-4. View

17.

Fernie G, Bennett D, Currie J, Perrin J, Reid I . Detecting objective and subjective cognitive effects of electroconvulsive therapy: intensity, duration and test utility in a large clinical sample. Psychol Med. 2014; 44(14):2985-94. DOI: 10.1017/S0033291714000658. View

18.

Aruta A . Shocking waves at the museum: the Bini-Cerletti electro-shock apparatus. Med Hist. 2011; 55(3):407-12. PMC: 3143851. DOI: 10.1017/s0025727300005482. View

19.

McCrae N . 'A violent thunderstorm': Cardiazol treatment in British mental hospitals. Hist Psychiatry. 2006; 17(65 Pt 1):67-90. DOI: 10.1177/0957154X06061723. View

20.

Duman R, Vaidya V . Molecular and cellular actions of chronic electroconvulsive seizures. J ECT. 1998; 14(3):181-93. View